Rudolf Binder

Title: Rudolf Binder: Innovator in Pharmaceutical Dosage Forms

Introduction

Rudolf Binder is a notable inventor based in Mittelbiberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work has led to advancements that benefit both the industry and patients.

Latest Patents

Rudolf Binder holds a patent for a capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative. This invention relates to a suspension formulation containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate. The patent details the processes for preparing the suspension formulation and the capsule, as well as the packaging material for the finished product.

Career Highlights

Rudolf Binder is associated with Boehringer Ingelheim International GmbH, where he has been instrumental in advancing pharmaceutical technologies. His expertise in formulation science has contributed to the development of effective and innovative drug delivery systems.

Collaborations

Throughout his career, Rudolf has collaborated with esteemed colleagues such as Roman Messerschmid and Thomas Bock. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

Rudolf Binder's contributions to pharmaceutical dosage forms exemplify the impact of innovation in medicine. His patent and collaborative efforts highlight the importance of research and development in improving healthcare solutions.